Qube Research & Technologies (QRT)
CRDF icon

Qube Research & Technologies (QRT)’s Cardiff Oncology CRDF Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37,245
Closed -$99.4K – 3505
2024
Q3 		$99.4K Sell
37,245
-3,419
-8% -$8.08K ﹤0.01% 2745
2024
Q2 		$90.3K Sell
40,664
-86,619
-68% -$326K ﹤0.01% 2626
2024
Q1 		$680K Buy
127,283
+127,231
+244,675% +$338K ﹤0.01% 2369
2023
Q4 		$77 Hold
52
– – ﹤0.01% 4043
2023
Q3 		$72 Buy
+52
New +$88 ﹤0.01% 3788
2022
Q4 		– Sell
-29,996
Closed -$46K – 2547
2022
Q3 		$46K Sell
29,996
-3,042
-9% -$7.32K ﹤0.01% 2152
2022
Q2 		$73K Buy
+33,038
New +$55.3K ﹤0.01% 2039
2021
Q3 		– Sell
-15,335
Closed -$102K – 2292
2021
Q2 		$102K Sell
15,335
-45,312
-75% -$384K ﹤0.01% 1946
2021
Q1 		$562K Sell
60,647
-35,798
-37% -$435K 0.01% 1109
2020
Q4 		$1.74M Buy
+96,445
New +$1.7M 0.02% 670

Other funds holding CRDF

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return